Besponsa (Inotuzumab Ozogamicin) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Besponsa. Always confirm against the full prescribing information.
100 interactions
Acebutolol
The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Inotuzumab ozogamicin.
Level 1 evidence
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Inotuzumab ozogamicin.
Level 1 evidence
Adagrasib
The risk or severity of QTc prolongation can be increased when Adagrasib is combined with Inotuzumab ozogamicin.
Level 1 evidence
Adenosine
The risk or severity of QTc prolongation can be increased when Adenosine is combined with Inotuzumab ozogamicin.
Level 1 evidence
Albuterol
The risk or severity of QTc prolongation can be increased when Albuterol is combined with Inotuzumab ozogamicin.
Level 1 evidence
Alcaftadine
The risk or severity of QTc prolongation can be increased when Alcaftadine is combined with Inotuzumab ozogamicin.
Level 1 evidence
Alfuzosin
The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Inotuzumab ozogamicin.
Level 1 evidence
Amantadine
The risk or severity of QTc prolongation can be increased when Amantadine is combined with Inotuzumab ozogamicin.
Level 1 evidence
Amifampridine
The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Inotuzumab ozogamicin.
Level 1 evidence
Amiodarone
The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Inotuzumab ozogamicin.
Level 1 evidence
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Inotuzumab ozogamicin.
Level 1 evidence
Amitriptyline
The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Inotuzumab ozogamicin.
Besponsa (Inotuzumab Ozogamicin) has 437 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Besponsa (Inotuzumab Ozogamicin) has 6 major, 266 moderate, and 165 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Besponsa. Always confirm against the full prescribing information.